Evidence map›Paper›PMID 38053332›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024

TLR9-independent CD8

Sandeep R P Kumar, Moanaro Biswas, Di Cao, Sreevani Arisa, Maite Muñoz-Melero, Anh K Lam, Annie R Piñeros, Reuben Kapur, Tsuneyasu Kaisho, Randal J Kaufman and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. The deLIVERed promises of gene therapy: Past, present, and future of liver-directed gene therapy.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  13. Gene therapy for hemophilia - From basic science to first approvals of "one-and-done" therapies.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  14. The curious case of AAV immunology.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Role of FoxP3Human gene therapy · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Sandeep R P KumarDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University, Indianapolis, IN, USA.
Moanaro BiswasDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University, Indianapolis, IN, USA.
Di CaoDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University, Indianapolis, IN, USA.
Sreevani ArisaDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University, Indianapolis, IN, USA.
Maite Muñoz-MeleroDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University, Indianapolis, IN, USA.
Anh K LamDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University, Indianapolis, IN, USA.
Annie R PiñerosDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University, Indianapolis, IN, USA.
Reuben KapurDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University, Indianapolis, IN, USA.
Tsuneyasu KaishoDepartment of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama, Japan.
Randal J KaufmanCenter for Genetic Disorders and Aging Research, Samford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
Weidong XiaoDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University, Indianapolis, IN, USA.
Dmitry M ShayakhmetovLowance Center for Human Immunology, Emory Vaccine Center, Departments of Pediatrics and Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Cox TerhorstDivision of Immunology, Beth Israel Deaconess Medical Center (BIDMC), Boston, MA, USA.
Ype P de JongDivision of Gastroenterology & Hepatology, Weill Cornell Medicine, New York, NY, USA.
Roland W HerzogDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University, Indianapolis, IN, USA. Electronic address: rwherzog@iu.edu.
Indiana University – Purdue University Indianapolis · USBeth Israel Deaconess Medical Center · USCornell University · USDiscovery Institute · USEmory University · USWakayama Medical University · JP

Funding

Tumor Microenvironment and Metastasis ProgramP30CA082709 · NCI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Sara K Quinney · 1999 to 2026
$59.3M
Toward Safer Gene Therapy for Hemophilia AP01HL160472 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI Roland W. Herzog · 2022 to 2026
$15.1M
Project-005U54DK106846 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI Reuben Kapur, Karen Elizabeth Pollok · 2015 to 2026
$9.7M
Enhancing immune regulation in gene therapy for hemophiliaR01HL131093 · NHLBI · UNIVERSITY OF FLORIDA · PI Ype Peter De Jong, Roland W. Herzog · 2016 to 2026
$7.2M
Immunology of Factor IX Gene Transfer to LiverR01AI051390 · NIAID · UNIVERSITY OF FLORIDA · PI HERZOG, ROLAND W. · 2002 to 2022
$6.7M
Mechanisms of adenovirus neutralizationR01AI107960 · NIAID · EMORY UNIVERSITY · PI SHAYAKHMETOV, DMITRY, STEWART, PHOEBE L · 2014 to 2024
$6.5M
Role of p21 activated kinase in LeukemogenesisR01CA173852 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI KAPUR, REUBEN · 2014 to 2025
$3.4M
Mechanistic factors limiting utility of adenovirus vectors for treatment of neoplaR01CA267694 · NCI · EMORY UNIVERSITY · PI Dmitry Shayakhmetov · 2022 to 2026
$3.1M
Molecular mechanisms of adenovirus neutralizationR37AI107960 · NIAID · EMORY UNIVERSITY · PI PHOEBE L STEWART, Dmitry Shayakhmetov · 2026 to 2026
$806k
BD FACSAria SystemS10OD012270 · OD · INDIANA UNIVERSITY INDIANAPOLIS · PI SROUR, EDWARD F · 2013 to 2013
$516k
NCI NIH HHS P30 CA082709NCI NIH HHS R01 CA173852NCI NIH HHS R01 CA267694NHLBI NIH HHS P01 HL160472NHLBI NIH HHS R01 HL131093NIAID NIH HHS R01 AI051390NIAID NIH HHS R37 AI107960NIDDK NIH HHS U54 DK106846NIH HHS S10 OD012270
6 · The paper itself

Abstract

Upon viral infection of the liver, CD8

Indexed as

CD8-Positive T-LymphocytesMyeloid Differentiation Factor 88AnimalsCapsid ProteinsDendritic CellsInterleukin-1LiverMiceToll-Like Receptor 9Capsid ProteinsInterleukin-1Myeloid Differentiation Factor 88Tlr9 protein, mouseToll-Like Receptor 9AAVCD8(+) T cellIL-1IL-1 receptorinnate immunityKupffer cellliver gene therapyplasmacytoid dendritic cellToll-like receptor

Identifiers

PMID38053332
PMCPMC10861967
OpenAlexW4389346484

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.